据消息人士和备忘录，VinFast(VFS.O)暂停了在印度本地生产三款电动车的计划。

At an Aug. 31 H1 2026 results briefing, Zhipu AI founder Tang Jie rejected criticism that the firm only performs fine‑tuning and said the next‑generation base model will expand in size while explicitly controlling activated parameters to avoid slower inference and higher costs. Zhipu said it has deployed scaled inference on roughly 100,000 Chinese chips, cutting per‑token inference cost about 80% since the start of the year. GLM‑5.3‑Flash is the company’s first model to run entirely on domestic chip clusters under large real‑world traffic; end‑to‑end service performance is about 3x the initial hardware baseline. Tang said GLM‑6.0 will target “self‑evolution,” with the primary research challenge being the model’s ability to judge when to stop and when to self‑correct rather than simply increasing parameter count.

China's National Essential Medicines List (2026 edition) takes effect today, Sept. 1. Issued by the National Health Commission, the National Administration of Traditional Chinese Medicine and the National Disease Control Bureau, the list—used as the basis for drug allocation and use in medical institutions—adds 68 chemical drugs and biologics. The update targets high‑incidence chronic and common diseases and broadens covered disease categories, with a specific emphasis on increasing the range of pediatric‑appropriate medicines.